Isotretinoin therapy for acne vulgaris: a re-evaluation of the need for measurements of plasma lipids and liver function tests
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
A retrospective analysis of patients receiving isotretinoin for acne was performed, in order to determine the necessity for routine testing of lipid profiles and liver function tests during therapy. Data were analysed from 209 individuals, 113 (69 males, 44 females) of whom had been treated with 1 mg/kg/day, and 96 (67 males, 29 females) with 0.5 mg/kg/day. There were no significant changes in any of the tests of liver function. There were significant elevations in both plasma cholesterol and triglycerides at 8 and 16 weeks (P < 0.01) for both dose schedules, which were significant in both male and female subjects (P < 0.001). All the individuals with elevated cholesterol (> 6.5 mmol/l) at 16 weeks had elevated cholesterol at the onset of therapy. Triglyceride concentrations were elevated at 8 weeks, but there was no further increase thereafter. It was not possible to predict which subjects would become hypertriglyceridaemic from pretreatment lipid estimations. In conclusion, there appears to be little evidence to support the previously recommended regular biochemical monitoring of liver function and lipid profiles in patients who are treated with isotretinoin for 16 weeks. It would appear prudent to ensure that there is neither liver disease nor hyperlipidaemia prior to the onset of therapy, and to determine the triglyceride response to therapy on one occasion after 4 weeks' treatment. This change in patient management should result in considerable savings both in patient time and in blood collection and analysis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Changes in plasma lipids and lipoproteins during isotretinoin therapy for acne.
Bershad, S., Rubinstein, A., Paterniti, J. R., Le, N.-A., Poliak, S. C., Heller, B., Ginsberg, H. N., Fleischmajer, R., & Brown, W. V. (1985) · New England Journal of Medicine · doi:10.1056/nejm198510173131604 · Cited by 217
Gavish, D. (1987) · Archives of Internal Medicine · doi:10.1001/archinte.1987.00370040087015 · Cited by 14
Cited by
Current Use and Future Potential Role of Retinoids in Dermatology
Orfanos, C. E., Zouboulis, C. C., Almond-Roesler, B., & Geilen, C. C. (1997) · Drugs · doi:10.2165/00003495-199753030-00003 · Cited by 330
Haider, A. (2004) · JAMA · doi:10.1001/jama.292.6.726 · Cited by 273
Zane, L. T., Leyden, W. A., Marqueling, A. L., & Manos, M. M. (2006) · Archives of Dermatology · doi:10.1001/archderm.142.8.1016 · Cited by 183
“In addition, differences in dietary practices may contribute to the discrepancies in serum lipid level abnormalities seen between our study and those conducted in other countries.(8,9,12) Overall, the cumulative incidence of new abnormalities in liver transaminase level was low (11%), and most elevations were mild (91…”
BackgroundResultLaboratory Monitoring During Isotretinoin Therapy for Acne: A Systematic Review and Meta-analysis
Lee, Y. H., Scharnitz, T. P., Muscat, J., Chen, A., Gupta-Elera, G., & Kirby, J. S. (2016) · JAMA Dermatology · doi:10.1001/jamadermatol.2015.3091 · Cited by 120
Barbieri, J. S., Shin, D. B., Wang, S., Margolis, D. J., & Takeshita, J. (2020) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2019.06.025 · Cited by 87
Metadata
- Authors
- BARTH, J. H., MACDONALD-HULL, S. P., MARK, J., JONES, R. G., & CUNLIFFE, W. J.
- Venue
- British Journal of Dermatology
- Publisher
- Oxford University Press (OUP)
- Published
- 1993-12
- Volume
- 129
- Issue
- 6
- Pages
- 704-707
- ISSN
- 0007-0963 (ISSN-L)
- 1365-2133
- OpenAlex
- W2024721053
- Cited by
- 95
- References
- 2
- FWCI
- 2.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Isotretinoin therapy for acne vulgaris: a re-evaluation of the need for measurements of plasma lipids and liver function tests. https://app.cochat.ai/papers/10.1111/j.1365-2133.1993.tb03336.x
- The paper
- BARTH, J. H., MACDONALD-HULL, S. P., MARK, J., JONES, R. G., & CUNLIFFE, W. J. (1993). Isotretinoin therapy for acne vulgaris: a re-evaluation of the need for measurements of plasma lipids and liver function tests. British Journal of Dermatology. https://doi.org/10.1111/j.1365-2133.1993.tb03336.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.